SIGMA'S $100.2 million "underlying profit" (see main story in today's Pharmacy Daily) was impacted by the previously announced one-off $11.4 million insurance recovery and an $8.3 million doubtful debt provision relating to a single pharmacy group.
CEO Mark Hooper stressed that "while disappointing, they are both one-off impacts reflecting historical issues and are not reflective of systemic operational or structural issues".
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Mar 17
